Navigation Links
EUCODIS Bioscience Launches Lipase Portfolio
Date:9/21/2009

VIENNA, Austria, September 21 /PRNewswire/ -- EUCODIS Bioscience, a company developing, customizing, manufacturing, and marketing enzymes for the chemical industry, announced today that it has launched the first enzymes of its lipase portfolio. EUCODIS Bioscience currently offers 12 lipases that have been selected to cover a broad range of potential industrial applications.

Lipases are an enzyme family that is widely used across the chemical industry, including the pharmaceutical, cosmetics, textiles, and food and feed industries. EUCODIS Bioscience offers customers to supply lipases of interest up to the kilogram scale. The Company can also customize promising lipases to properties specified by the customer, using its proven in-vivo recombination technology.

"With the launch of our lipases portfolio we enter a market of USD 300 million," said Rudy Pandjaitan, PhD, CEO of EUCODIS Bioscience. "In recent years our organization has accumulated a unique expertise in the development, customization, and manufacturing of industrial lipases. Our customers can select from our portfolio of currently 12 lipases which include both enzymes designed for well-established uses as well as those with exciting novel properties. Going forward we plan to expand our lipase platform and to leverage the industrial expertise we can offer in this area."

About EUCODIS Bioscience

EUCODIS Bioscience GmbH develops, customizes, manufactures, and markets industrial enzymes.

EUCODIS Bioscience' products help customers in the chemical, pharmaceutical, and food and feed industries to make manufacturing processes more efficient and cleaner, and to generate products with superior properties.

EUCODIS Bioscience originally focused on developing enzymes for industrial partners, including GlaxoSmithKline, Henkel, and Lohmann Animal Health. Since 2009, the Company also markets its own product
'/>"/>

SOURCE EUCODIS Bioscience
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. EUCODIS Bioscience Launches Beta-Lactamase for Antibiotics and Diagnostics Industries
2. EUCODIS Bioscience Signs Research Agreement With Genencor
3. EUCODIS Bioscience and Lohmann Animal Health Announce Achievement of Major Development Milestone
4. EUCODIS Bioscience Appoints Thomas Fischer as Chief Financial Officer
5. Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
6. YM BIOSCIENCES REPORTS NIMOTUZUMAB APPROVED FOR MARKETING IN MEXICO
7. American Capital Receives $182 Million In Proceeds From Sale of Axygen Bioscience
8. Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
9. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
10. Neurocrine Biosciences Secures Committed Equity Financing Facility
11. Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015 According to a new ... Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract ... Trial), by End Users - Global Forecast to 2020", ... reach USD 2,107.99 million by 2020 from USD 1,034.93 ... Browse more than 75 ...
(Date:7/30/2015)... the globe, ISN improves the efficiency and effectiveness of contractor management systems. ISN,s online ... contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In More Than 80 Countries ... in Dallas, TX , ISN has additional offices in Calgary ...
(Date:7/30/2015)... New York, NY (PRWEB) , ... July 30, 2015 , ... As part of its ... raw material and technical service business units, Whitehouse Laboratories is pleased ... facility will be adjacent to the Container Center of Excellence and will be strictly dedicated ...
(Date:7/29/2015)... BANGALORE , July 30, 2015 ... Cell Market - Growth, Trends & Forecasts (2015-2020), , published ... worth US$ 30.25 billion by the end of 2020, with ... globally accounting for more than 40% of the global market ... grow at a CAGR of 13.7% during the period of ...
Breaking Biology Technology:Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3
... (Nasdaq and MTA: CTIC) announced today that it has ... validated the expanded Pediatric Investigation Plan ("PIP") that CTI ... relapsed or refractory, aggressive non-Hodgkin,s lymphoma (NHL).  Following the ... and comment or approve the content of pediatric plan. ...
... Dinks -- an arts and crafts material used by children ... Northwestern University laboratory. A team of nanoscientists is using the ... way to create, test and mass-produce large-area patterns on the ... on the cheap could benefit from this method," said Teri ...
... A new paper by University of Notre Dame physicist ... of an enduring mystery in chemical physics. More than ... mechanics, the Noble Prize-winning physicist Neils Bohr predicted so-called ... due to electrons making transitions between discrete energy levels ...
Cached Biology Technology:EMEA Validates Cell Therapeutics, Inc.'s (CTI) Expanded Pixantrone Pediatric Investigation Plan (PIP) 2EMEA Validates Cell Therapeutics, Inc.'s (CTI) Expanded Pixantrone Pediatric Investigation Plan (PIP) 3The nano world of Shrinky Dinks 2New paper offers breakthrough on blinking molecules phenomenon 2
(Date:7/7/2015)... , June 30, 2015 ... has announced the addition of the "Capacitive ... offering. To this date, fingerprint sensing ... technology and fingerprint sensors are well developed. This ... sensing technology. The domain of capacitive ...
(Date:7/2/2015)... July 2, 2015 Fingerprint Cards has ... FPC1145 and FPC1155 from the distributor World Peace Industrial Group ... distributors in Asia . Deliveries are planned ... will be used by smartphone manufacturers in Asia ... in the communicated revenue guidance of approximately 2,200 MSEK for ...
(Date:6/25/2015)... , June 25, 2015 ... Market by Type (Swipe & Area), Technology, Material (Optical ... Healthcare, Commercial Security & Others) & Geography - ... marketsandmarkets, the said market is expected to reach ... 17.1%. Browse 76 market Tables ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4
... Strasbourg 18/04/12 - Technology has transformed the way humans interact ... big ideas that will drive growth in marine and maritime ... and policy will gather at the 3rd Marine Board Forum ... Marine Board has convened this flagship event on the understanding ...
... April 2012 -- Several new studies that may help ... individual patients and of their tumors are being presented ... "A major goal of lung cancer treatment is ... Fiona Blackhall from The Christie NHS Foundation Trust in ...
... can be used to boost an enzyme,s function by as much ... detergents and a host of other products. In a paper ... team led by Pratul Agarwal of the Department of Energy,s Oak ... nature and it happens in the blink of an eye. ...
Cached Biology News:New technologies for a blue future 2Advances in personalized medicine for lung cancer 2Advances in personalized medicine for lung cancer 3Advances in personalized medicine for lung cancer 4Advances in personalized medicine for lung cancer 5ORNL process improves catalytic rate of enzymes by 3,000 percent 2